Labomed S.A. is a Greek privately owned contract development and manufacturing organization (CDMO), resulting from the fusion of LaboServe S.A. and Documed Limited. Focused on comprehensive services for Generic and Value-Added medications in the form of oral liquid, Labomed has amassed substantial expertise, intellectual property rights, and projects aimed at commercialization in Europe and the US. The company's manufacturing facilities, which are approved by the European Union Good Manufacturing Practice (EU-GMP), are based in Athens, Greece, and are backed by strong quality control systems and a team of specialists and highly skilled personnel. It is this blend of knowledge and infrastructure that sets Labomed apart.